INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS
INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS
复制标题
DOI:
10.1093/clinids/18.3.273
复制
发表时间:
1994-03-01
影响因子:
11.8
通讯作者:
DONOWITZ, GR
中科院分区:
文献类型:
--
作者:
SABLE, CA;DONOWITZ, GR
In 1993,, 15,000 allogeneic and autologous bone marrow transplantations were carried out worldwide (M. Bortim, International Bone Marrow Transplant Registry, Milwaukee; personal communication). Transplantation has been utilized with increasing frequency for treatment of ma-lignant and nonmalignant hematologic diseases, solid tumors, and metabolic and genetic disorders. Infection and graft-vs.-host disease (GVHD) remain the major sources of morbidity and mortality in recipients of bone marrow transplants. Infections occur as a direct result of the predictable, sequential suppression of host defenses that is caused by marrow transplantation (table 1). The sever-ity and type of infection also depend on a number of other factors including the type of transplant, the presence and degree ofhistocompatibility mismatch, T lymphocyte manip-ulation (depletion), type of graft-vs.-host prophylaxis employed, severity of GVHD, and viral and fungal infections occurring before transplantation. Previous antibiotic exposures, including antibiotic prophylaxis, may also help to de-fine the infections that develop.While it would be overly simplistic to suggest that specific infections occur only at specific times in the transplantation process, it is nevertheless helpful to divide the transplanta-tion process into specific phases, each of which is characterized by specific host defense defects and is associated with a specific group of infections.